BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37576877)

  • 1. Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review.
    Wang D; Zhang F; Feng W; Pan J; Yuan T
    Front Oncol; 2023; 13():1206833. PubMed ID: 37576877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report.
    Corral Sánchez MD; Galán Gómez V; Sastre Urgelles A; Plaza López de Sabando D; Rubio Aparicio P; Martínez Martínez L; Alonso Gamarra E; Pozo Kreilinger JJ; Regojo Zapata RM; López Gutiérrez JC; Antolín Alvarado E; Gómez Martín F; Sánchez Torres AM; Marín Manzano E; González Del Valle L; Pérez-Martínez A
    Pediatr Hematol Oncol; 2021 Aug; 38(5):504-509. PubMed ID: 33622165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series.
    Corral Sánchez MD; Jiménez Carrascoso R; Rubio Aparicio P; Plaza López de Sabando D; Sastre Urgelles A; Pozo-Kreilinger JJ; López Gutiérrez JC; Gómez Cervantes M; Ortiz Cruz EJ; Pérez-Martínez A
    Clin Transl Oncol; 2023 Nov; 25(11):3307-3311. PubMed ID: 37097530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limb salvage of an infant with infantile fibrosarcoma using TRK inhibitor larotrectinib.
    Sahni S; Rastogi S; Yadav R; Barwad A
    Ecancermedicalscience; 2023; 17():1575. PubMed ID: 37533946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
    Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
    Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Larotrectinib as an Effective Therapy in Congenital Infantile Fibrosarcoma: Report of Two Cases.
    Lapeña LM; Caldas MCS; Ramírez C; Basilio MS; Junco PT; Rodríguez-Laguna L; Martínez-González V; Marín-Manzano E; Perez-Martinez A; Lopez-Gutierrez JC
    European J Pediatr Surg Rep; 2022 Jan; 10(1):e76-e79. PubMed ID: 35761904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib.
    Caldwell KJ; De La Cuesta E; Morin C; Pappo A; Helmig S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28330. PubMed ID: 32452122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent and metastatic infantile fibrosarcoma: a case report].
    Lagree M; Toutain F; Revillon Y; Gaussin G; Marie-Cardine A; Lemoine F; Vannier JP
    Arch Pediatr; 2011 Jan; 18(1):28-32. PubMed ID: 21084177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
    Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
    Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization.
    Adem C; Gisselsson D; Dal Cin P; Nascimento AG
    Mod Pathol; 2001 Dec; 14(12):1246-51. PubMed ID: 11743047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distant metastatic spread of molecularly proven infantile fibrosarcoma of the chest in a 2-month-old girl: case report and review of literature.
    van Grotel M; Blanco E; Sebire NJ; Slater O; Chowdhury T; Anderson J
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):231-3. PubMed ID: 24276045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
    Sheng WQ; Hisaoka M; Okamoto S; Tanaka A; Meis-Kindblom JM; Kindblom LG; Ishida T; Nojima T; Hashimoto H
    Am J Clin Pathol; 2001 Mar; 115(3):348-55. PubMed ID: 11242790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
    Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
    J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal congenital/infantile fibrosarcoma: a new clinico-pathological entity?
    Berrebi D; Fournet JC; Boman F; Fabre M; Philippe-Chomette P; Branchereau S; Fréneaux P; Bouron-Dal Soglio D; Michon J; Peuchmaur M
    Pediatr Surg Int; 2015 Apr; 31(4):375-9. PubMed ID: 25652760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.